Skip to main content
SpringerLink
Log in

Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094)

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Drugs which block the biosynthesis of leukotrienes and prostaglandins may have potential in the treatment of psoriasis and other skin diseases. The biochemical and anti-inflammatory activity of 9-phenylnonanohydroxamic acid (BMY 30094) is described. BMY 30094 inhibited human neutrophil 5-lipoxygenase with an IC50 of 5.7 μM. BMY 30094 also blocked human platelet cyclooxygenase and lipoxygenase with IC50 values of 15.2 and 15.0 μM, respectively. Topical application of this compound blocked arachidonic acid and 12-O-tetradecanoylphorbol ester-induced mouse skin inflammation with activity comparable to that observed for lonapalene. The topical ED50 for BMY 30094 in the arachidonic acid-induced inflammation model is 2.2 μmoles/ear. In the sub-cutaneous carrageenan sponge assay in rats, BMY 30094 blocked LTB4 and PGE2 production and inhibited neutrophil migration. This compound would be a useful tool to determine the role of arachidonic acid metabolites in the etiology of inflammatory dermatoses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. K. Kragballe and J. J. Voorhees,Arachidonic acid and leukotrienes in dermatology. J. Invest. Dermatol.81, 293–296 (1983).

    PubMed  Google Scholar 

  2. G. A. Higgs, R. J. Flower and J. R. Vane,A new approach to anti-inflammatory drugs. Biochem. Pharmacol.28, 1959–1961 (1979).

    Article  PubMed  Google Scholar 

  3. S. Hammarstrom, M. Hamberg, B. Samuelsson, E. A. Duell, M. Stawiski and J. J. Voorhees,Increased concentrations of non esterified arachidonic acid, 12 l-hydroxy-5,8,10,14-elycosatetraenoic acid, prostaglandin E 2 and prostaglandin F 2 in epidermis of psoriasis. Proc. Natl. Acad. Sci. USA72, 5130–5134 (1975).

    PubMed  Google Scholar 

  4. S. Brain, R. Camp, P. Dowd, A. K. Black and M. Greaves,The release of leukotriene B 4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J. Invest. Dermatol,83, 70–73 (1984).

    Article  PubMed  Google Scholar 

  5. R. M. Barr, E. Wong, A. I. Mallet, L. A. Olins, and M. W. Greaves,The analysis of arachidonic acid metabolites in normal, uninvolved and lesional psoriatic skin. Prostaglandins28, 57–66 (1984).

    Article  PubMed  Google Scholar 

  6. N. A. Soter, R. A. Lewis, E. J. Corey and K. F. Austen,Local effects of synthetic leukotrienes in human skin. J. Invest. Dermatol.80, 115–119 (1983).

    Article  PubMed  Google Scholar 

  7. C. N. Ellis, J. D. Fallon, J. L. Heezen and J. J. Voorhees,Topical indomethacin exacerbates lesions of psoriasis. J. Invest. Dermatol.80, 362 (1983) (Abstract).

    Google Scholar 

  8. K. Kragballe and J. J. Voorhees,Arachidonic acid in psoriasis. Pathogenic role and pharmacological regulation. Acta. Derm. Venereol.120 (Suppl), 12–17 (1986).

    Google Scholar 

  9. A. Lassus and S. Forsstrom,A dimethoxynaphthalene derivative (RS-43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasis. Br. J. Dermatol.113, 103–106 (1985).

    PubMed  Google Scholar 

  10. R. Camp, A. K. Black, F. Cunningham, A. Mallet and M. Greaves,Pharmacological effects of topical lonapalene in psoriasis. J. Invest. Dermatol.90, 550 (1988) (Abstract).

    Google Scholar 

  11. A. Boyum,Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol.5 (Suppl 5), 9–15 (1976).

    Google Scholar 

  12. W. Boyle,An extension of the 51 Cr-release assay for the estimation of mouse cytotoxins. Transplantation6, 761–764 (1968).

    PubMed  Google Scholar 

  13. E. E. Opas, R. J. Bonney and J. L. Humes,Prostaglandin and leukotriene synthesis in mouse ears inflamed by arachidonic acid. J. Invest. Dermatol.84, 253–256 (1985).

    Article  PubMed  Google Scholar 

  14. J. M. Young, B. M. Wagner and D. A. Spires,Tachyphylaxis in 12-O-tetradecanoylphorbol acetate- and arachidonic acid-induced ear edema. J. Invest. Dermatol.80, 48–52 (1983).

    Article  PubMed  Google Scholar 

  15. A. Janoff, A. Klassen and W. Troll,Local vascular changes induced by the cocarcinogen, phorbol myristate acetate. Cancer Res.30, 2568–2571 (1970).

    PubMed  Google Scholar 

  16. R. P. Carlson, L. O'Neill-Davis, J. Chang and A. J. Lewis,Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents and Actions17, 197–204 (1985).

    Article  PubMed  Google Scholar 

  17. T. Nakadate, S. Yamamoto, E. Aizu and R. Kato,The inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. Jpn. J. Pharmacol.38, 161–168 (1985).

    PubMed  Google Scholar 

  18. M. Gschwendt, G. Furstenberger, W. Kittstein, E. Besemfelder, W. E. Hull, H. Hagedorn, H. J. Opferkuch and F. Marks,Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1 H-n.m.r. and GC-MS spectroscopy. Carcinogenesis7, 449–455 (1986).

    PubMed  Google Scholar 

  19. J. A. Salmon, P. M. Simmons and S. Moncada,The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation. J. Pharm. Pharmacol.35, 808–813 (1983).

    PubMed  Google Scholar 

  20. J. M. Young, D. A. Spires, C. J. Bedord, B. Wagner, S. J. Ballaron and L. M. DeYoung,The mouse ear inflammatory response to topical arachidonic acid. J. Invest. Dermatol.82, 367–371 (1984).

    Article  PubMed  Google Scholar 

  21. A. Blackham, A. A. Norris and F. A. Woods,Role of neutrophils and arachidonic acid metabolites in experimental models of ear inflammation in mice. Br. J. Pharmacol.86, 786P (1985).

  22. E. C. Arner, B. L. Rule, M. S. Rudnick and W. Galbraith,Arachidonic acid-induced ear edema: correlation of swelling with production of lipoxygenase products. Agents and Actions16, 600–601 (1985) (abstract).

    Google Scholar 

  23. K. Kragballe, L. Desjarlais and J. J. Voorhees,Leukotrienes B 4,C 4 and D 4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br. J. Dermatol.113, 43–52 (1985).

    PubMed  Google Scholar 

  24. L. Levine,Arachidonic acid transformations in tumor promotion. Adv. Cancer Res.35, 49–79 (1981).

    PubMed  Google Scholar 

  25. G. Furstenberger, H. Richter, N. E. Fusenig and F. Marks,Arachidonic acid and prostaglandin E 2 release and enhanced cell proliferation induced by the phorbol ester TPA in a murine epidermal cell line. Cancer Lett.11, 191–198 (1981).

    Article  PubMed  Google Scholar 

  26. C. L. Ashendel and R. K. Boutwell,Prostaglandin E and F levels in mouse epidermis are increased by tumor-promoting phorbol esters. Biochem. Biophys. Res. Commun.90, 623–627 (1979).

    Article  PubMed  Google Scholar 

  27. G. Furstenberger and F. Marks,Prostaglandins, epidermal hyperplasia and skin tumor promotion. InProstaglandins, Leukotrienes and Cancer vol. 3 (Eds. K. Honn and L. J. Marnett), Arachidonic acid metabolism and tumor promotion (Eds. S. M. Fischer and T. J. Slaga), pp 49–72, Martinus-Nyhoff, Boston 1985.

    Google Scholar 

  28. A. Crummey, G. P. Harper, E. A. Boyle and F. R. Mangan,Inhibition of arachidonic acid-induced ear oedema as a model for assessing topical anti-inflammatory compounds. Agents and Actions20, 69–76 (1987).

    PubMed  Google Scholar 

  29. G. A. Higgs, R. L. Follenfant and L. G. Garland,Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses. Br. J. Pharmacol.94, 547–551 (1988).

    PubMed  Google Scholar 

  30. S. J. Foster, M. E. McCormick, A. Howarth and D. Aked,Leukocyte recruitment in the subcutaneous sponge implant model of acute inflammation in the rat is not mediated by leukotriene B 1. Biochem. Pharmacol.35, 1709–1717 (1986).

    Article  PubMed  Google Scholar 

  31. R. Roncucci, G. Lambelin, M. J. Simon and K. Debast,In vitro action of bufexamac and selected hydroxamic acids on isolated rat liver lysosomes. Arch. Int. Pharmacodyn. Ther.203, 348–367 (1973).

    PubMed  Google Scholar 

  32. G. Orzalesi, R. Selleri, O. Caldini, I. Volpato, F. Innocenti, J. Colome, A. Sacristan, G. Varez and G. Pisaturo,Determination of Ibuproxam and its metabolites in the plasma and urine of rats. Arzneim-Forsch27(I), 1012–1015 (1977).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology Research, Bristol-Myers Squibb Co., Pharmaceutical Research and Development Division, 100 Forest Avenue, 14213, Buffalo, New York, USA

    K. M. Tramposch Ph.D., F. C. Zusi, S. A. Marathe, P. L. Stanley, X. Nair, S. A. Steiner & J. W. Quigley

Authors
  1. K. M. Tramposch Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. C. Zusi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. A. Marathe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. L. Stanley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. X. Nair
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. A. Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. W. Quigley
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tramposch, K.M., Zusi, F.C., Marathe, S.A. et al. Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094). Agents and Actions 30, 443–450 (1990). https://doi.org/10.1007/BF01966310

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966310

Keywords

Search

Navigation